| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.3 | 0.02 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.29 | 0.08 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.05 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.22 | 0.09 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.21 | 0.09 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.2 |